Press Releases
Looking for more press releases? Explore our full press release archive by date to access past announcements, news updates, and media releases published on Sci-Tech Europe.
Arbor Biotechnologies Announces First Patient Dosed at Mayo Clinic in the redePHine Phase 1/2 Study of ABO-101, an Investigational Gene Editing Treatment for Primary Hyperoxaluria Type 1
GlobeNewswire, Inc.
·
July 30, 2025
- ABO-101 was well tolerated with no serious adverse events or dose-limiting toxicities reported in the 28-days following dosing - Phase 1/2 redePHine study (NCT06839235) dose escalation ongoing with enrollment at Mayo Clinic in the US and plans...
Amarin Reports Second Quarter 2025 Financial Results
GlobeNewswire, Inc.
·
July 30, 2025
-- European Partnership with Recordati Established to Maximize VAZKEPA® in Europe; Global Corporate Restructuring Implemented with Anticipated $70 Million in Operating Expense Savings Over Next 12 Months -- -- Q2 2025 Financial Performance...
Corbus Pharmaceuticals Announces Upcoming Presentation of Dose Expansion Phase 1/2 Clinical Data for its Nectin-4 Targeting ADC CRB-701 at the 2025 ESMO Annual Congress
GlobeNewswire, Inc.
·
July 30, 2025
NORWOOD, Mass., July 30, 2025 (GLOBE NEWSWIRE) -- Corbus Pharmaceuticals Holdings Inc. (NASDAQ: CRBP), a clinical-stage company focused on oncology and obesity, announced today that an abstract on updated clinical data from its Phase 1/2 clinical...
Intelligent Bio Solutions Secures Major Drug Testing Tender with Leading London Transport Operator
GlobeNewswire, Inc.
·
July 30, 2025
NEW YORK, July 30, 2025 (GLOBE NEWSWIRE) -- Intelligent Bio Solutions Inc. (Nasdaq: INBS) ("INBS" or the "Company"), a medical technology company delivering intelligent, rapid, non-invasive testing solutions, today announced it has secured a major...
Profusa Announces Initial $1 Million Bitcoin Investment to Initiate Its Digital Asset Treasury Strategy
GlobeNewswire, Inc.
·
July 30, 2025
BERKELEY, Calif, July 30, 2025 (GLOBE NEWSWIRE) -- Profusa, Inc. (“Profusa” or the “Company”) (NASDAQ: PFSA), a commercial stage digital health company pioneering the next generation of technology platform enabling the continuous monitoring of an...
Half-Year Report on the DBV Technologies Liquidity Contract with ODDO BHF
GlobeNewswire, Inc.
·
July 28, 2025
AMF Regulated Information Châtillon, France, July 28, 2025 Half-Year Report on the DBV Technologies Liquidity Contract with ODDO BHF DBV Technologies (Euronext: DBV – ISIN: FR0010417345 – Nasdaq Stock Market: DBVT), a clinical-stage...
Parking Management Solutions Market to Hit $10.62B by 2032, Driven by Smart City Adoption | DataM Intelligence
EIN Presswire
·
July 30, 2025
Parking tech soars: Market to hit $10.62B by 2032 with 8.32% CAGR. IoT, AI, and EV-ready infrastructure are reshaping urban mobility. AUSTIN, TX, UNITED STATES, July 30, 2025 /EINPresswire.com/ -- The Parking Management Solutions Market was...
NewAmsterdam Pharma Presents Positive Data from BROADWAY Trial Demonstrating Statistically Significant Reductions in Key Alzheimer’s Disease Biomarkers at AAIC 2025
GlobeNewswire, Inc.
·
July 30, 2025
-- Pre-specified analysis shows obicetrapib significantly reduced absolute levels of plasma p-tau217, a key biomarker of Alzheimer’s disease pathology, in both the full analysis set (p=0.0019) and in ApoE4 carriers (p=0.0215), supporting CETP...
VERSES® Provides Update on Genius™ Adoption
GlobeNewswire, Inc.
·
July 30, 2025
VANCOUVER, British Columbia, July 30, 2025 (GLOBE NEWSWIRE) -- VERSES AI Inc. (CBOE: VERS) (OTCQB: VRSSF) (“VERSES” or the “Company”), a cognitive computing company specializing in next-generation agentic software systems, shared an update on the...
TG Therapeutics to Host Conference Call on Second Quarter 2025 Financial Results and Business Update
GlobeNewswire, Inc.
·
July 30, 2025
NEW YORK, July 30, 2025 (GLOBE NEWSWIRE) -- TG Therapeutics, Inc. (NASDAQ: TGTX), today announced that a conference call will be held, Monday, August 4, 2025, at 8:30 AM ET to discuss results for the second quarter of 2025 and provide a business...
Immutep Quarterly Activities Report Q4 FY25
GlobeNewswire, Inc.
·
July 30, 2025
Media Release The pivotal TACTI-004 Phase III trial in first line non-small cell lung cancer (1L NSCLC) continues to build momentum and is recruiting patients at a growing number of activated clinical sites and countries Trial-in-Progress poster...
Sensei Biotherapeutics to Present Clinical Data from the Phase 1 Dose Expansion Cohort of Solnerstotug at the ESMO Congress 2025
GlobeNewswire, Inc.
·
July 30, 2025
BOSTON, July 30, 2025 (GLOBE NEWSWIRE) -- Sensei Biotherapeutics, Inc. (NASDAQ: SNSE), a clinical stage immuno-oncology company focused on the discovery and development of next generation therapeutics for cancer patients, announced today that...
Teva's Innovative Portfolio Fuels 10th Consecutive Quarter of Growth in Q2 2025; Increases 2025 Revenue Outlook for Key Innovative Products and EPS, and Reaffirms All Other Components
GlobeNewswire, Inc.
·
July 30, 2025
On track for 30% operating profit margin by 2027 in line with our Pivot to Growth Strategy. Q2 2025 shows 10th consecutive quarter of year-over-year (YoY) revenue growth; Revenues of $4.2 billion, +1% in local currencyterms (“LC“)excluding Japan...
Appendix 4C – Q4 FY25 Quarterly Cash Flow Report
GlobeNewswire, Inc.
·
July 30, 2025
Highlights Granted U.S. FDA Fast Track Designation for ATH434 to treat Multiple System Atrophy (MSA) Reported positive topline data from open-label Phase 2 clinical trial of ATH434 in MSA Presented additional analyses from the ATH434-201 trial...
Tenaya Receives Positive Safety Reviews from Independent DSMBs to Advance Both TN-201 and TN-401 Gene Therapy Clinical Trials as Designed
GlobeNewswire, Inc.
·
July 30, 2025
Enrollment in Both Dose Cohorts of the MyPEAK™-1 Phase 1b/2 Clinical Trial of TN-201 for Hypertrophic Cardiomyopathy (HCM) Complete; Follow-up Data from Cohort 1 and Initial Data from Cohort 2 Expected in Fourth Quarter of 2025 First Patient Dosed...
SEALSQ’s Strategic Investment in WISeSat Propels Satellite Constellation Growth and Accelerates Commercialization of Post-Quantum Space Technology
GlobeNewswire, Inc.
·
July 28, 2025
Geneva, Switzerland, July 28, 2025 (GLOBE NEWSWIRE) -- SEALSQ Corp (NASDAQ: LAES) ("SEALSQ" or "Company"), a company that focuses on developing and selling Semiconductors, PKI, and Post-Quantum technology hardware and software products, today...
Enlight Expands Its Executive Leadership Team
GlobeNewswire, Inc.
·
July 30, 2025
Gilad Yavetz, founder of Enlight, to serve as Executive chairman of the board Adi Leviatan to be appointed CEO, bringing a proven track record of executive leadership from leading global companies; Yair Seroussi to serve as vice chairman This...
Wood Pulp Market Analysis of Rising Business Opportunities with Prominent Investment, 2030
EIN Presswire
·
July 30, 2025
The global wood pulp market is undergoing a dynamic transformation, fueled by technological advancements and shifting consumer preferences. WILMINGTON, DE, UNITED STATES, July 30, 2025 /EINPresswire.com/ -- The global wood pulp market is...
Pancreatic Cancer Phase 2a Study with Can-Fite’s Namodenoson Achieved Over 50% Enrollment Milestone
GlobeNewswire, Inc.
·
July 30, 2025
Primary endpoint is safety; Namodenoson continues to demonstrate a favorable safety profile Ramat Gan, Israel, July 30, 2025 (GLOBE NEWSWIRE) -- Can-Fite BioPharma Ltd. (NYSE American: CANF) (TASE: CANF), a clinical-stage biotechnology company...
GOGL - Update on Merger with CMB.TECH and Change of VPS Registrar
GlobeNewswire, Inc.
·
July 28, 2025
Hamilton, Bermuda, 28 July, 2025 – Reference is made to the stock exchange announcement made by Golden Ocean Group Limited (NASDAQ: GOGL & Euronext Oslo Børs: GOGL) ("Golden Ocean") and CMB.TECH NV (NYSE: CMBT & Euronext Brussels: CMBT)...